JENNIFER NARDONE: Open Payments
NPI 1316217029 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,692 in 201 payments from 24 companies in 2025. Trend: 2023 $2,436 · 2024 $3,260 · 2025 $2,692
Food & beverage: $2,607Education: $85
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 21 | $328 |
| Janssen Biotech, Inc. | 26 | $278 |
| Regeneron Healthcare Solutions, Inc. | 15 | $267 |
| ABBVIE INC. | 30 | $259 |
| Arcutis Biotherapeutics, Inc. | 28 | $259 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $248 |
| Amgen Inc. | 11 | $181 |
| Incyte Corporation | 17 | $141 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $102 |
| Novartis Pharmaceuticals Corporation | 5 | $86 |
Products named: TREMFYA, DUPIXENT, Zoryve, NEMLUVIO, SKYRIZI, OTEZLA, ILUMYA, OPZELURA.
Industry payments across NJ — which companies pay providers there.
